Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How to Build a Yard That Helps Monarchs During Spring Migration - 2RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- 3‘Inoculation’ helps people spot political deepfakes, study finds
- 4L.A.'s most famous midcentury home, the Stahl House, is on the market for the 1st time, at $11K per square foot: See inside
- 5Humpback whale stranded on Germany's Baltic coast frees itself
- The Main 15 Powerful Business Heads of Today
- Vote in favor of Your Number one Cake Type
- The Solution to Defeating Tarrying: Systems for Expanded Efficiency
- Smartwatches: Remain Associated and Dynamic
- 5 Eating routine Well disposed Snacks to Keep You Fulfilled
- 'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- Jillian Michaels put me at the center of a body positivity debate. She's not entirely wrong about obesity.
- Energy security rifts widen in Europe
- Four countries to boycott Eurovision 2026 over Israel’s inclusion
